Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Kitada

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|August 6, 2011
Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitorJohn L Stebbins, Surya K De, Petra Pavlickova, et al.
Cancer Letters|September 11, 2008
Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonistsJun Wei, Michele F Rega, Shinichi Kitada, et al.
Cancer Chemotherapy and Pharmacology|March 16, 2007
Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetateLee Jia, Lori C Coward, Corenna D Kerstner-Wood, et al.
Blood|August 15, 2002
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1Irene M Pedersen, Shinichi Kitada, Lorenzo M Leoni, et al.
Cancer Research|March 22, 2003
Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapyAaron D Schimmer, Irene Munk Pedersen, Shinichi Kitada, et al.
Journal of Medicinal Chemistry|June 27, 2009
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, Shinichi Kitada, Michele F Rega, et al.
Journal of Medicinal Chemistry|November 2, 2010
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, Shinichi Kitada, John L Stebbins, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancerRoger S Jackson, William Placzek, Ana Fernandez, et al.
Blood|September 28, 2002
The triterpenoid CDDO induces apoptosis in refractory CLL B cellsIrene M Pedersen, Shinichi Kitada, Aaron Schimmer, et al.
Journal of Medicinal Chemistry|May 7, 2010
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, John L Stebbins, Shinichi Kitada, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|August 6, 2011
Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitorJohn L Stebbins, Surya K De, Petra Pavlickova, et al.
Cancer Letters|September 11, 2008
Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonistsJun Wei, Michele F Rega, Shinichi Kitada, et al.
Cancer Chemotherapy and Pharmacology|March 16, 2007
Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetateLee Jia, Lori C Coward, Corenna D Kerstner-Wood, et al.
Blood|August 15, 2002
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1Irene M Pedersen, Shinichi Kitada, Lorenzo M Leoni, et al.
Cancer Research|March 22, 2003
Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapyAaron D Schimmer, Irene Munk Pedersen, Shinichi Kitada, et al.
Journal of Medicinal Chemistry|June 27, 2009
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, Shinichi Kitada, Michele F Rega, et al.
Journal of Medicinal Chemistry|November 2, 2010
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, Shinichi Kitada, John L Stebbins, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancerRoger S Jackson, William Placzek, Ana Fernandez, et al.
Blood|September 28, 2002
The triterpenoid CDDO induces apoptosis in refractory CLL B cellsIrene M Pedersen, Shinichi Kitada, Aaron Schimmer, et al.
Journal of Medicinal Chemistry|May 7, 2010
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, John L Stebbins, Shinichi Kitada, et al.
Pageof 5